Search research articles
Contact Us
Filters
Showing results (11-20 of 263) with videos related to
Page
of 27
Sort By:
European Urology
|
October 9, 2019
The Balancing Act: Assessing Treatment Burden Versus Treatment Benefit with Evolving Metastatic Hormone-sensitive Prostate Cancer Data
Christopher J Sweeney, Himisha Beltran
The Journal of Urology
|
June 7, 2002
Resistance to luteinizing hormone releasing hormone agonist therapy for metastatic prostate cancer
Eardie A Curry, Christopher J Sweeney
Urologic Oncology
|
July 16, 2005
Germ cell tumors: an update of recent data and review of active protocols in stage I and metastatic disease
Noah M Hahn, Christopher J Sweeney
Current Opinion in Urology
|
August 18, 2017
Chemotherapy for oligometastatic prostate cancer
Tanya B Dorff, Christopher J Sweeney
Journal of Oncology Practice
|
January 4, 2017
Evolving Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer
Jessica M Clement, Christopher J Sweeney
Nature Reviews. Clinical Oncology
|
August 9, 2017
Prostate cancer: A new standard-of-care for advanced-stage disease
Anis A Hamid, Christopher J Sweeney
European Urology
|
December 20, 2015
It Is Time to Harmonize the Design and Conduct of Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer
Srikala S Sridhar, Christopher J Sweeney
Current Opinion in Urology
|
May 13, 2022
The role of chemotherapy in metastatic prostate cancer
Irbaz B Riaz, Christopher J Sweeney
Integrated Environmental Assessment and Management
|
March 14, 2024
Soil-specific outcomes in the OECD 216 Nitrogen Transformation Test
Christopher J Sweeney, Melanie Bottoms, Lennart Schulz
Integrated Environmental Assessment and Management
|
July 15, 2023
Considerations for the inclusion of metabarcoding data in the plant protection product risk assessment of the soil microbiome
Christopher J Sweeney, Rishabh Kaushik, Melanie Bottoms
Page
of 27
Search research articles
Search
Showing results (11-20 of 263) with videos related to
Sort By:
Page
of 27
European Urology
|
October 9, 2019
The Balancing Act: Assessing Treatment Burden Versus Treatment Benefit with Evolving Metastatic Hormone-sensitive Prostate Cancer Data
Christopher J Sweeney, Himisha Beltran
The Journal of Urology
|
June 7, 2002
Resistance to luteinizing hormone releasing hormone agonist therapy for metastatic prostate cancer
Eardie A Curry, Christopher J Sweeney
Urologic Oncology
|
July 16, 2005
Germ cell tumors: an update of recent data and review of active protocols in stage I and metastatic disease
Noah M Hahn, Christopher J Sweeney
Current Opinion in Urology
|
August 18, 2017
Chemotherapy for oligometastatic prostate cancer
Tanya B Dorff, Christopher J Sweeney
Journal of Oncology Practice
|
January 4, 2017
Evolving Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer
Jessica M Clement, Christopher J Sweeney
Nature Reviews. Clinical Oncology
|
August 9, 2017
Prostate cancer: A new standard-of-care for advanced-stage disease
Anis A Hamid, Christopher J Sweeney
European Urology
|
December 20, 2015
It Is Time to Harmonize the Design and Conduct of Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer
Srikala S Sridhar, Christopher J Sweeney
Current Opinion in Urology
|
May 13, 2022
The role of chemotherapy in metastatic prostate cancer
Irbaz B Riaz, Christopher J Sweeney
Integrated Environmental Assessment and Management
|
March 14, 2024
Soil-specific outcomes in the OECD 216 Nitrogen Transformation Test
Christopher J Sweeney, Melanie Bottoms, Lennart Schulz
Integrated Environmental Assessment and Management
|
July 15, 2023
Considerations for the inclusion of metabarcoding data in the plant protection product risk assessment of the soil microbiome
Christopher J Sweeney, Rishabh Kaushik, Melanie Bottoms
Page
of 27